Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Barely two in 10 Americans would take a first-generation coronavirus vaccine if President Trump told them it was safe — one of several new measures of his sinking credibility in the latest wave of the Axios-Ipsos Coronavirus Index.
Details: Given eight scenarios and asked how likely they were to try the vaccine in each case, respondents said they'd be most inclined if their doctor vouched for its safety (62%), followed by insurance covering the full cost (56%) or the FDA saying it's safe (54%).
- Acting on Trump's assurances came in dead last as an option (19%).
- People said they'd be more likely to take it if they had to pay $100 out of pocket or visit a hospital to get it.
The big picture: With just five weeks left in the election, Week 26 of our national survey offers additional signs that trust in the president and his administration are continuing to fall over the handling of the pandemic.
- Just 32% said they trust the federal government to provide them with accurate information about COVID-19, down four percentage points from a week ago and a new low for the index.
- Trust in the White House fell to 28%, and trust in Trump himself fell to 27% — also new lows.
- Trust in Joe Biden is higher, but not exactly a vote of confidence: 47% of respondents said they trust him, consistent with past weeks.
What they're saying: "You don't want to be the least credible on one of the primary issues of the day," said Cliff Young, president of Ipsos U.S. Public Affairs.
- This week's findings show that people still prioritize science over politics when it comes to putting something in their bodies — but Young said the depths of Trump's measures point to something more.
- "Not only is he not an expert, but he's undermined his own credibility" in the way that "he's flip-flopped and twisted and spun things when it comes to the science around the virus."
By the numbers: Republicans were the least likely to act on their doctor's word (56%) and the most likely to follow Trump's (40%).
- Just 9% of Democrats and 15% independents said they'd be likely to take the first-generation vaccine if Trump said it was safe.
- Just 4% of Black respondents and 16% of Hispanic respondents said they'd act on that cue from Trump, compared with 23% of white respondents.
- Overall, men were more willing than women to say they'd try a first-generation vaccine.
What we're watching: At least for now, Americans indicate they're willing to put others' needs ahead of their own when it comes to a vaccine — or perhaps they're content to let others serve as a first test.
- In this week's survey, respondents were asked on a scale of one to seven to rank how important it was for various groups in society to be able to take the first-generation vaccine.
- They prioritized health care workers, followed by residents of nursing homes or assisted living facilities, people over 65 and teachers.
- They placed themselves at the bottom of the list in terms of who should get it first, along with people younger than 30.
- Politicians were toward the bottom on people's rankings of whose access was most important to protect — and led the rankings for whose access should be least important.
Methodology: This Axios/Ipsos Poll was conducted Sept. 24–27 by Ipsos’ KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,075 general population adults age 18 or older.
- The margin of sampling error is ± 3.2 percentage points at the 95% confidence level.